Mario Raviglione

Mario C.B. Raviglione is Adjunct  Professor of Global Health (Full Professor, 2018-2025,) at the University of Milan, Italy, Senior Visiting Scientist at IARC, and Honorary Professor at Queen Mary University of London, UK. He is also Chair of ReLAY, the translational research track of the CRDF Global/NIH supported project FAST-TB. At the University of Milan, he established and coordinated the Master Course in Global Health and co-directed the Centre for Multidisciplinary Action in Global Health (MAGH). Between 1991 and 2017, he worked at the World Health Organization (WHO) in Geneva where he was Director of the Global Tuberculosis (TB) Programme (2003-2017) and responsible for global policies and standards on TB care, control and research. After joining WHO in 1991, he contributed to the development of the DOTS strategy, set up global surveillance systems for TB and drug-resistant TB, established numerous operational research projects, and coordinated global policy making and guideline development in all fields of TB. In particular, he conceived and directed the development of the Stop TB Strategy in 2006 and of the current End TB Strategy 2016-2030 approved by the World Health Assembly in 2014. As a WHO official he worked with all countries worldwide. He graduated in medicine from Turin University, and trained in internal medicine, infectious diseases and AIDS at Cabrini Medical Centre, New York, and Beth Israel Hospital, Harvard Medical School, Boston. He has authored nearly 400 publications on TB, AIDS, infectious diseases, COVID-19 and global health. He edited books on TB and was chief editor of “Global Health Essentials” (Springer, 2023). His h-index is 123, and his work has been cited >70,000 times. He has served as a visiting professor and taught at major universities worldwide and has lectured at top international health conferences in over 60 countries. He received several international awards for his work in global health and tuberculosis.